Sales revenues for March 2022
Sofia, Bulgaria, April 5, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for March 2022 the Company recorded a decrease in sales of 23% compared to the same month of the previous year, incl.
Individual annual financial results for 2021
Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2021
Individual Audited Financial Report according to BFSC standards as at 31 December 2021
2021 Annual Financial Statements - ESEF format
Sales revenues for February 2022
Sofia, Bulgaria, March 7, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for February 2022 the Company recorded an increase in sales of 71% compared to the same month of the previous year, incl. 69% increase in domestic sales and 72% increase in export sales.
Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
Sofia, Bulgaria, 1 March 2022 – According to the requirements of Art. 100t of LPOS and in connection with Art. 114, para. 9 of the Law on Public Offering of Securities, “Sopharma” AD announces that today, according to a decision of the Board of Directors dated February 11, 2022, the company concluded the following transactions falling within the scope of Art. 114, para. 2 of the LPOS:
1. “Sopharma” AD as a Lessee, concluded Annex № 12 to the Lease Agreement dated August 8, 2012 (the “Agreement”) with “Sopharma Imoti” REIT, UIC 175059266.